Circulating Omentin-1 and Chronic Temporomandibular Disorder Pain Public Deposited
- Last Modified
- March 19, 2019
- Creator
-
Harmon, Jennifer
- Affiliation: School of Dentistry, Division of Allied Dental Education, Dental Hygiene Master's Program
- Abstract
- Objective: Literature implicates circulating inflammatory cytokines in pain and TMD. One anti- inflammatory adipokine, omentin-1, has decreased expression in inflammatory conditions. This study tested the hypothesis that circulating levels of omentin-1 were lower in individuals with TMD than healthy controls. Methods: A case-control design of chronic TMD cases (n=90) and TMD-free controls (n=54) were selected from the study named OPPERA. Omentin-1 levels were measured in blood plasma samples using an enzyme-linked immunosorbent assay (ELISA). Logistic regression estimated odds ratios (OR) and 95% confidence limits (CL) for the association between omentin-1 and TMD. Results: Mean omentin-1 concentration was lower in TMD cases (413.5 μg/ml) than controls (464.8 μg/ml), but the difference was not statistically significant. Odds of TMD decreased 36% per standard deviation increase in circulating omentin-1 (adjusted OR=0.64, 95% CL: 0.43, 0.96. P=0.031). Conclusion: Decreased omentin-1 in TMD cases supports the view that TMD pain is mediated by anti-inflammatory pathways.
- Date of publication
- May 2015
- Keyword
- Subject
- DOI
- Identifier
- Resource type
- Rights statement
- In Copyright
- Advisor
- Nackley, Andrea
- Sanders, Anne
- Essick, Gregory K.
- Wilder, Rebecca S.
- Degree
- Master of Science
- Degree granting institution
- University of North Carolina at Chapel Hill Graduate School
- Graduation year
- 2015
- Language
- Publisher
- Place of publication
- Chapel Hill, NC
- Access
- There are no restrictions to this item.
- Parents:
This work has no parents.
Items
Thumbnail | Title | Date Uploaded | Visibility | Actions |
---|---|---|---|---|
|
Harmon_unc_0153M_15466.pdf | 2019-04-09 | Public |
|